Home » Topics » BioWorld Science

BioWorld Science
RSS

Eisai claims cerebral antiischemic

April 5, 1996

PPI-368 selected for development

April 5, 1996

Schering-Plough claims felbamate metabolite

April 5, 1996

Roche Bioscience claims antiemetic drugs

April 5, 1996

SYM-2206 for seizure prevention

April 5, 1996

Anticonvulsants claimed by Bristol-Myers Squibb

April 5, 1996

Stanford investigators identify epilepsy gene

April 5, 1996

Aristogen to offer genetic diagnostic services in Germany

April 5, 1996

Neugenesis profile

April 5, 1996

FDA approves Laser system for myopia

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.